Skip to main content

Table 2 Age- and sex-adjusted prevalence of type 2 diabetes, hypertension, and dyslipidemia at baseline according to physical activity categories

From: Aerobic, muscle-strengthening, and flexibility physical activity and risks of all-cause and cause-specific mortality: a population-based prospective cohort of Korean adults

Prevalent conditions at baseline

 

N

Type 2 diabetes,a %

Hypertension,b %

Dyslipidemia,c %

Number of prevalent health conditionsd (0–3), mean ± SE

Total aerobic physical activity (including walking; IPAQ guideline) e

Low

13,764

10.7

29.9

44.4

0.85 ± 0.007

Moderate

11,622

10.8

29.8

42.3

0.83 ± 0.007

High

8993

9.6

29.5

40.5

0.80 ± 0.008

P valuef

 

0.003

0.76

< 0.001

< 0.001

Moderate- to vigorous-intensity aerobic physical activity (MET-h/wk) g

0

16,926

11.3

29.8

43.2

0.84 ± 0.006

0.1–4.9

1988

10.1

30.1

44.3

0.85 ± 0.017

5.0-9.9

2134

8.9

29.2

42.2

0.80 ± 0.017

10.0-19.9

3121

9.6

30.5

42.7

0.83 ± 0.014

20.0-49.9

5309

9.5

29.7

43.0

0.82 ± 0.011

≥ 50.0

4901

9.8

29.5

40.0

0.79 ± 0.011

P valuef

 

< 0.001

0.89

< 0.001

0.001

Muscle-strengthening physical activity (d/wk)

0

25,321

10.6

30.0

43.3

0.84 ± 0.005

1

2095

9.9

29.6

41.5

0.81 ± 0.017

2

2104

9.6

28.3

42.6

0.80 ± 0.017

3–4

2776

10.2

27.9

39.9

0.78 ± 0.015

≥ 5

2083

10.4

31.4

39.7

0.82 ± 0.017

P valuef

 

0.52

0.02

< 0.001

< 0.001

Flexibility physical activity (d/wk)

0

16,162

10.9

30.3

43.4

0.85 ± 0.006

1

3223

10.2

29.9

43.3

0.83 ± 0.014

2

3817

10.0

29.3

42.0

0.81 ± 0.012

3–4

5557

9.9

28.6

42.0

0.81 ± 0.010

≥ 5

5620

10.0

29.7

41.3

0.81 ± 0.010

P valuef

 

0.08

0.12

0.03

0.001

  1. Abbreviations: SE, Standard Error; IPAQ, International Physical Activity Questionnaire; MET, metabolic equivalent task
  2. a Type 2 diabetes was defined as those who reported a prior diagnosis of type 2 diabetes, were currently taking diabetic medication, or had measured fasting blood glucose concentrations ≥ 126 mg/dL or HbA1c ≥ 6.5% at baseline.
  3. b Hypertension was defined as having a prior diagnosis of hypertension, currently taking antihypertensive medication, or having a measured systolic blood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg at baseline.
  4. c Dyslipidemia was defined as having a prior diagnosis of dyslipidemia, currently taking medication or on treatment, or having measured total cholesterol concentrations ≥ 240 mg/dL, triglyceride concentrations ≥ 200 mg/dL, LDL cholesterol concentrations ≥ 160 mg/dL, or HDL cholesterol concentrations ≤ 40 mg/dL.
  5. d Summed number of prevalent health conditions (type 2 diabetes, hypertension, and dyslipidemia)
  6. e The “high” category of total aerobic activity included participants with ≥ 3 days of vigorous-intensity activity achieving total aerobic activity of ≥ 25 MET-h/wk; or ≥ 7 days of any combination of walking, moderate-intensity, or vigorous-intensity activities achieving total aerobic physical activity of ≥ 50 MET-h/wk. The “moderate” category included participants who satisfied at least one of the following 3 criteria: (1) ≥ 3 days of vigorous-intensity activity of at least 20 min/d; (2) ≥ 5 days of moderate-intensity activity and/or walking of at least 30 min/d; or (3) ≥ 5 days of any combination of walking, moderate-intensity, or vigorous-intensity activities achieving total aerobic physical activity of ≥ 10 MET-h/wk. The “low” category included participants who were not meeting criteria for “moderate” and “high” categories.
  7. fP value was estimated by F test for ANOVA.
  8. g Walking was not included when estimating MET-h/wk.
Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us